Clinical trial

A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer

NCT07853209

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-26

PhasePHASE3

Study timeline

Study start (actual)2026-01-26Date precision: day

Registry last updated2026-10-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

mCRPCunresolved

Interventions

[177-Lu]LudotadipepDRUG

Best supportive care/standard of care (BSC/SOC) aloneOTHER

Sponsors & collaborators

FutureChemlead sponsor

Mapped research locations

SeoulSouth Korea6

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07853209 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.